France-based life sciences venture capital firm Sofinnova today announced that its portfolio company Myricx Bio has reached ...

AlzeCure Pharma has signed an out-licensing and collaboration agreement with Denmark’s privately held QuantumCell, granting ...

M&A was again a big feature in last week's news, with AbbVie’s acquisition of Apogee Therapeutics, along with its atopic ...

India’s pharmaceutical industry is witnessing a surge in global partnerships, with countries such as Switzerland, Uzbekistan, ...

India’s Orchid Pharma is in advanced negotiations to out-license its breakthrough antibiotic enmetazobactam in the USA, a move that could mark the company’s commercial entry into the world’s largest ...

Danish biotech company Muna Therapeutics has named Michel Detheux as chief executive as it prepares to move its lead ...

US biotech Viridian Therapeutics saw its shares climb more than 10% to $19.81 in after-hours activity Friday, when it ...

The European Commission (EC) has approved Maviret (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C virus ...

US drugmaker United Therapeutics yesterday revealed that it has acquired Thymmune Therapeutics, a privately held, pre-clinical stage biotechnology company.

Danish drugmaker Novo Nordisk has won conditional UK marketing authorization for Wegovy (semaglutide) in adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-advanced ...

US oncology biotech Revolution Medicines has reported early Phase I/II data for zoldonrasib-based combinations in RAS G12D-mutant metastatic pancreatic ductal adenocarcinoma (PDAC), supporting two ...

As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on patient-reported outcomes to carve out space for Briumvi ...